Improving treatments for type 1 diabetes by helping beta cells
Development of platforms for beta cell-specific delivery and ligand discovery
This project aims to find new ways to deliver treatments directly to the cells that make insulin, offering a better option for people with type 1 diabetes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11128690 on NIH RePORTER |
What this research studies
For people with type 1 diabetes, managing blood sugar often means lifelong insulin injections or a pancreas transplant, which has its own challenges like donor scarcity and immune rejection. This research looks for new ways to help the body's own insulin-producing cells, called beta cells, grow and multiply. We are developing precise methods to deliver medicines only to these beta cells, which could make treatments more effective and reduce side effects. This targeted approach could overcome the limitations of current therapies and offer a more lasting solution.
Who could benefit from this research
Good fit: Patients with type 1 diabetes who currently rely on insulin injections or are considering islet transplantation might eventually benefit from this research.
Not a fit: Patients with other forms of diabetes not related to beta cell destruction, or those without diabetes, would not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to new therapies that help the body produce its own insulin again, reducing or eliminating the need for external insulin in people with type 1 diabetes.
How similar studies have performed: While the idea of stimulating beta cell growth has been explored, this project focuses on developing novel, highly targeted delivery methods for these therapies.
Where this research is happening
Cambridge, United States
- Broad Institute, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Choudhary, Amit — Broad Institute, INC.
- Study coordinator: Choudhary, Amit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.